The bill
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
S. 3204, 119th Congress β read as touching Hospitals & Health Systems.
Sponsored by
Sen. King, Angus S., Jr. [I-ME]
ID: K000383
Follow the money
The bill
S. 3204, 119th Congress β read as touching Hospitals & Health Systems.
The sponsor
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
24 itemised contributions to this sponsor, pulled from FEC filings.
Track this bill's progress through the legislative process
Latest Action
Invalid Date
π Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
No summary available
Sen. King, Angus S., Jr. [I-ME]
Congress 119 β’ 2024 Election Cycle
No PAC contributions found
No committee contributions found
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 41 nodes and 24 connections (52 secondary connections hidden)
Total contributions: $87,600
Showing top 17 donors by contribution amount
Which industries are materially affected by specific provisions in this bill. 3 helped.
Section 2(h)(1) directs the CBO Director to determine if proposed legislation would result in net reductions in budget outlays through preventive health care, which could lead to scoring that favors preventive health investments, benefiting hospitals and health systems that provide such services.
Section 2(h)(1)(B) includes 'effective, innovative health care interventions' demonstrated by clinical trials and epidemiological models, which could encompass pharmaceutical preventive therapies, potentially benefiting drug makers if such interventions are scored favorably.
Section 2(h)(1)(B) references 'innovative health care interventions' supported by clinical trials and meta-analysis, which could include biotech-developed preventive therapies, potentially benefiting biotech firms if such interventions are scored for budget savings.
For each industry this bill affects, here's what the sponsor (Sen. King, Angus S., Jr. [I-ME])received from donors associated with that industry during the 2022βpresent cycles. Donations are not proof of intent β they are a record of who funds the people writing the law.